{
    "title": "US drug giant Eli Lilly halts plans for new London base as it blasts Britain's 'stifling' regulations and punishing tax regime",
    "url": "https://www.dailymail.co.uk/money/markets/article-12125755/US-drug-giant-Eli-Lilly-blasts-stifling-UK-regulations.html",
    "date": "2023-05-25",
    "keywords": [
        "london",
        "investment",
        "share",
        "innovation",
        "environment",
        "stock",
        "account",
        "government",
        "bell",
        "boss",
        "listing",
        "tax",
        "fund",
        "uk",
        "hub",
        "europe",
        "countrys",
        "access",
        "research",
        "van",
        "product",
        "market",
        "money",
        "aj",
        "platform",
        "founder",
        "america",
        "capital",
        "factory",
        "sir",
        "sector",
        "fee",
        "giant",
        "base",
        "warning",
        "punishing",
        "move",
        "competitiveness",
        "cost",
        "property",
        "agent",
        "cbre",
        "squarefoot",
        "startup",
        "yesterday",
        "hold",
        "eli",
        "potential",
        "biotech",
        "talent",
        "ambition",
        "life",
        "timethe",
        "discovery",
        "processesthe",
        "vicepresident",
        "stephen",
        "soelen",
        "treatment",
        "youre",
        "saying",
        "something",
        "nothing",
        "value",
        "challenger",
        "bank",
        "bond",
        "havoc",
        "tieup",
        "supermarket",
        "article",
        "diy",
        "headquarters",
        "basingstoke",
        "hampshire",
        "centre",
        "bracknell",
        "berkshire",
        "blow",
        "science",
        "superpower",
        "york",
        "investmentmichael",
        "summersgill",
        "job",
        "andy",
        "sense",
        "company",
        "street",
        "usbeing",
        "doesnt",
        "case",
        "roadshow",
        "criticism",
        "soriot",
        "firm",
        "astrazeneca",
        "system",
        "decision",
        "ireland"
    ],
    "category": [
        "money",
        "markets"
    ]
}